Term: | velpatasvir |
|
Accession: | CHEBI:133009
|
browse the term
|
Definition: | A complex organic heteropentacyclic compound that is a hepatitis C virus nonstructural protein 5A inhibitor used in combination with sofosbuvir (under the brand name Epclusa) for treatment of patients with chronic hepatitis C of all six major genotypes. |
Synonyms: | exact_synonym: | methyl {(2S)-1-[(2S,5S)-2-(9-{2-[(2S,4S)-1-{(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl}-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-4-yl}-1,11-dihydro[2]benzopyrano[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl}carbamate |
| related_synonym: | Formula=C49H54N8O8; GS-5816; GS5816; InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1; InChIKey=FHCUMDQMBHQXKK-CDIODLITSA-N; SMILES=C(N1[C@@H](C)CC[C@H]1C2=NC=3C=CC=4C=C5C6=CC=C(C7=CN=C([C@@H]8C[C@H](COC)CN8C(=O)[C@@H](C=9C=CC=CC9)NC(=O)OC)N7)C=C6COC5=CC4C3N2)(=O)[C@H](C(C)C)NC(=O)OC |
| xref: | CAS:1377049-84-7; Drug_Central:5154; PMID:26183611; PMID:26519191; PMID:26551051; PMID:26551263; PMID:26569658; PMID:26571066; PMID:26575258; PMID:26956698; PMID:27015627; PMID:27119242; PMID:27119243; PMID:27135094; PMID:27135095; PMID:27177605; PMID:27240903; PMID:27353271; PMID:27429714; PMID:27444413; PMID:27486033; PMID:27486034; PMID:27508349; Reaxys:23709173; Wikipedia:Velpatasvir |
|
|